China Aflibercept Market Report 2021: An Anti-VEGF Drug – Relevant Concepts, Sales 2018-2020, Major Manufacturers 2018-2020, Prices 2020-2021, & Prospects 2021-2025 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Investigation Report on China's Aflibercept Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Aflibercept is an anti-VEGF drug, mainly used to treat neovascular age-related macular degeneration...

Full "IntellAsia: Resources" article